SEC Form 4 · accession 0001651844-18-000022
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James George Robinson
Director
Period of report
Nov 9, 2018
Accepted (ET)
Nov 13, 2018 · 9:39 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 9, 2018 | P | 327 | $2.05 | A | 3,210,240 | D | |
| Common Stock | Nov 9, 2018 | P | 100 | $2.059 | A | 3,210,340 | D | |
| Common Stock | Nov 9, 2018 | P | 5,573 | $2.0597 | A | 3,215,913 | D | |
| Common Stock | Nov 9, 2018 | P | 6,300 | $2.1229 | A | 3,222,213 | D | |
| Common Stock | Nov 9, 2018 | P | 700 | $2.1362 | A | 3,222,913 | D |
Table II — derivative securities
No Table II lines on this filing.